OGN Investors Have Opportunity to Join Organon & Co. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Organon & Co. (“Organon” or “the Company”) (NYSE: OGN) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Seeking Alpha reports in an article titled, “Organon drops after dividend cut” that the Company announced a massive drop in its quarterly dividend as part of its Q1 2025 earnings release on May 1, 2025. The Company’s dividend dropped from $0.28 per share in the previous quarter to just $0.02 per share. Based on this news, shares of Organon fell by more than 26% in intraday trading on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250501286406/en/